tiprankstipranks
RVL Pharmaceuticals (RVLPQ)
OTHER OTC:RVLPQ
US Market
Holding RVLPQ?
Track your performance easily

RVL Pharmaceuticals (RVLPQ) Income Statement

314 Followers

RVL Pharmaceuticals Income Statement

Last quarter (Q2 2023), RVL Pharmaceuticals's total revenue was $8.26M, a decrease of -2.25% from the same quarter last year. In Q2, RVL Pharmaceuticals's net income was $7.05M. See RVL Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 36.92M$ 49.72M$ 17.50M$ 27.76M$ 240.03M$ 263.70M
Cost of Revenue
$ -5.13M$ 9.46M$ 3.62M$ 3.29M$ 111.63M$ -140.08M
Gross Profit
$ 27.59M$ 40.27M$ 13.88M$ 24.47M$ 128.40M$ 123.62M
Operating Expense
$ -57.45M$ 85.94M$ 102.27M$ 115.12M$ 125.35M$ -222.16M
Operating Income
$ -68.67M$ -58.99M$ -82.75M$ -90.65M$ 3.05M$ 5.68M
Net Non Operating Interest Income Expense
$ -39.00K$ 253.00K$ -3.04M$ -4.09M$ -17.33M$ -20.13M
Other Income Expense
$ -9.61M$ -5.78M$ -13.94M$ 48.00K$ 283.70M$ 17.90M
Pretax Income
$ -68.54M$ -51.71M$ -82.53M$ -94.80M$ -297.98M$ -118.66M
Tax Provision
$ -277.00K$ -20.00K$ 315.00K$ -5.78M$ -27.12M$ -8.98M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -29.97M$ -27.93M$ -48.77M$ -21.77M$ -270.85M$ -109.68M
Basic EPS
$ -0.72$ -1.16$ -1.92$ -1.31--
Diluted EPS
$ -0.72$ -1.16$ -2.02$ -1.31$ -5.17$ -2.42
Basic Average Shares
$ 381.25M$ 89.80M$ 33.81M$ 60.65M$ 52.37M$ 45.28M
Diluted Average Shares
$ 381.25M$ 89.80M$ 67.35M$ 60.65M$ 52.37M$ 45.32M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ -62.58M$ 95.40M$ 105.89M$ 118.41M$ 236.98M$ -362.24M
Net Income From Continuing And Discontinued Operation
$ -68.27M$ -51.69M$ -64.92M$ -79.59M$ -270.85M$ -109.68M
Normalized Income
$ -33.24M$ -38.52M$ -55.52M---
Interest Expense
------
EBIT
$ -60.29M$ -48.60M$ -78.52M$ -90.70M$ -279.76M$ -97.87M
EBITDA
$ -58.78M$ -48.23M$ -70.34M$ -69.67M$ -221.41M$ -14.65M
Currency in USD

RVL Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis